What does biomedical — goodwill mean?

The total value of goodwill attributed to the Biomedical business segment.

How do you interpret biomedical — goodwill?

An increase suggests recent acquisitions in the biomedical space, while a decrease may indicate impairment charges or divestitures.

How does biomedical — goodwill compare across companies?

Commonly reported by diversified industrial and healthcare companies as part of segment-level intangible asset disclosures.

Chart Industries GTLS Biomedical — Goodwill

Discontinued — last reported Q2 '18

Similar metrics at other companies

TEC

TECHBiotechnology — Goodwill

$271.88M+6.6%

ALife Sciences and Applied Markets — Goodwill

$1.58B+0.3%

IRMedical — Goodwill

$203.2M0.0%

STEHealthcare /Life Sciences — Goodwill

$1.34B—

MOG.BMedical Devices — Goodwill

$61.8M—

BIO.BClinical Diagnostics — Goodwill

——

Other financials

Income statement

See full

Revenue$884.8M-11.7%

Gross profit$251.4M-26.0%

Operating income$52.6M-65.5%

Net income-$17.1M-135%

EPS (diluted)-$0.36-138%

Balance sheet

See full

Cash & equivalents$269.4M-9.6%

Total debt$3.9B+1.9%

Total equity$3.2B+5.3%

Total assets$9.7B+4.1%

Cash flow

See full

Operating cash flow-$248.0M-313%

CapEx$24.8M+23.4%

Free cash flow-$272.8M-241%

Valuation

See full

Market cap$9.96B+50.0%

Enterprise value$13.59B+33.6%

P/S2.4×+0.8×

Profitability

See full

Gross margin32.5%-1.3pp

Operating margin6.2%-10.1pp

Net margin-0.6%-6.7pp

FCF margin0.2%-10.3pp

Returns & leverage

See full

Return on equity-0.8%-9.8pp

Debt / equity1.2×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Chart Industries in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Chart Industries’s 10-Q, filed July 19, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does biomedical — goodwill mean?: The total value of goodwill attributed to the Biomedical business segment.
How do you interpret biomedical — goodwill?: An increase suggests recent acquisitions in the biomedical space, while a decrease may indicate impairment charges or divestitures.
How does biomedical — goodwill compare across companies?: Commonly reported by diversified industrial and healthcare companies as part of segment-level intangible asset disclosures.